Beam Global Income Taxes Disclosure
| 14. | INCOME TAXES |
The provision for income taxes consists of the following:
| 2025 | 2024 | |||||||
| Current: | ||||||||
| Federal | - | - | ||||||
| State | $ | 10 | $ | 14 | ||||
| Foreign | (164 | ) | 199 | |||||
|
| (154 | ) | 213 | |||||
| Deferred: | ||||||||
| Federal | - | - | ||||||
| State | - | - | ||||||
| Foreign | (252 | ) | (307 | ) | ||||
| (252 | ) | (307 | ) | |||||
|
| ||||||||
| Net benefit | $ | (406 | ) | $ | (94 | ) | ||
The components of loss from continuing operations before provision for income taxes consists of the following:
| Year Ended December 31, | ||||||
| 2025 | 2024 | |||||
| United States | $ | 19,975 | $ | 10,537 | ||
| International | 7,434 | 839 | ||||
| Total | $ | 27,409 | $ | 11,376 | ||
The Company’s tax expense differs from the “expected” tax expense for Federal income tax purposes, (computed by applying the United States Federal tax rate of 21% to loss before taxes). The following is a reconciliation of the Company’s effective tax rate on income and the statutory rate for the year ended December 31, 2025.
| December 31, 2025 | ||||||||
| $ | % | |||||||
| Tax benefit at the U.S. statutory rate | $ | (5,756 | ) | 21.00 | % | |||
| State and local income tax (net of FBOS) | 457 | % | ||||||
| Change in Valuation Allowance | 3,598 | % | ||||||
| Nontaxable or nondeductible items | (5 | ) | % | |||||
| Foreign tax effects: | ||||||||
| Serbia: | ||||||||
| Goodwill impairment | 995 | % | ||||||
| Rate differential | 446 | % | ||||||
| Prior year deferred true-up | (223 | ) | 0.82 | % | ||||
| Other | (73 | ) | 0.27 | % | ||||
| Other: | ||||||||
| Prior Year True-Up | 155 | % | ||||||
| Total | $ | (406 | ) | 1.48 | % | |||
As previously disclosed, prior to the adoption of ASU 2023-09, the difference between the provision (benefit) for income taxes and the amount computed by applying the U.S. federal income tax rate for the year ended December 31, 2024 is as follows:
| Year Ended December 31, | ||||
| 2024 | ||||
| Computed “expected” tax expense (benefit) | $ | (2,389 | ) | |
| State taxes, net of federal benefit | (761 | ) | ||
| Change in FV of Contingent Consideration | (982 | ) | ||
| Non-deductible stock options | 336 | |||
| Non-deductible items | 11 | |||
| Foreign tax rate differential | 69 | |||
| True-up to tax return | 210 | |||
| Change in deferred tax asset valuation allowance | 3,412 | |||
| Total | $ | (94 | ) | |
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The effects of temporary differences that gave rise to significant portions of deferred tax assets and liabilities are as follows:
| Year Ended December 31, | ||||||||
| 2025 | 2024 | |||||||
| Deferred tax assets: | ||||||||
| Stock options | $ | 1,531 | $ | 1,081 | ||||
| Deferred Revenue | 223 | 151 | ||||||
| Capitalized R&D | 600 | 828 | ||||||
| Patents/Intangible Assets | 2,589 | 1,424 | ||||||
| Lease Liability | 300 | 456 | ||||||
| Other | 444 | 310 | ||||||
| Net operating loss carryforward | 26,446 | 22,167 | ||||||
| Total gross deferred tax assets | 32,133 | 26,417 | ||||||
| Less: Deferred tax asset valuation allowance | (31,810 | ) | (25,913 | ) | ||||
| Total net deferred tax assets | 323 | 504 | ||||||
| Deferred tax liabilities: | ||||||||
| ROU Asset | (290 | ) | (442 | ) | ||||
| Depreciation | (1,236 | ) | (1,352 | ) | ||||
| Total deferred tax liabilities | (1,526 | ) | (1,794 | ) | ||||
| Total net deferred taxes | $ | (1,203 | ) | $ | (1,290 | ) | ||
As a result of the Company’s history of incurring operating losses, a valuation allowance has been established. The valuation allowance at December 31, 2025 was $31.8 million. The increase in the valuation allowance during 2025 was $5.9 million which was all recorded through deferred taxes.
At December 31, 2025, the Company has a Federal net operating loss carry forward of $92.8 million, of which $25.1 million is available to offset future net income through 2037. The net operating loss (“NOL”) expires during the years 2027 to 2037 and $67.7 million may be carried forward indefinitely and limited to offsetting 80% of taxable income. At December 31, 2025, the Company has a state net operating loss carryforward of $97.2 million and no foreign net operating loss carry forward. The utilization of the net operating loss carryforwards is dependent upon the ability of the Company to generate sufficient taxable income during the carryforward period. In the event that a significant change in ownership of the Company occurs as a result of the Company’s issuance of common stock, the utilization of the NOL carry forward will be subject to limitation under certain provisions of the Internal Revenue Code. Management does not presently believe that such a change has occurred.
No liability related to uncertain tax positions is recorded on the financial statements related to uncertain tax positions. There are no unrecognized tax benefits as of December 31, 2025. The Company does not expect that uncertain tax benefits will materially change in the next 12 months.
The Company will file U.S. Federal, California, Illinois, Michigan, New York, Tennessee, Texas and Wisconsin State tax returns, and a New York City tax return. All tax returns will remain open for examination by the Federal and State taxing authorities for three and four years, respectively, from the date of utilization of any net operating loss carryforwards.
The cash paid for income tax (net of refunds) during the year consists of $6 thousand for state income taxes and $4 thousand for foreign income taxes. Domestic income taxes included $3 thousand for New York City, $1 thousand for New York State, and $2 thousand for Texas. Foreign income taxes included $4 thousand for Serbia.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Apr 9, 2026 | Showing above |
| 2024 | Apr 11, 2025 | |
| 2023 | Apr 16, 2024 | |
| 2022 | Mar 31, 2023 | |
| 2021 | Mar 31, 2022 | |
| 2020 | Mar 30, 2021 | |
| 2019 | Mar 30, 2020 | |
| 2018 | Mar 20, 2019 | |
| 2017 | Apr 2, 2018 | |
| 2016 | Mar 31, 2017 | |
| 2015 | Mar 30, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.